Matson et al. find that the symbiotic microbiome improves tumor control, enhances T cell responses, and increases the effectiveness of anti-PD-L1 therapy in patients with metastatic melanoma, so maintaining a healthy gut microbiota helps patients fight against cancer [130]. Here, CD274 is linked to metastatic melanoma.